At a glance
- Originator Chauvin
- Class Antirheumatics; Thiazoles
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 16 Feb 1995 Discontinued-Preclinical for Rheumatic disorders (Unknown route)